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Materials and Methods 
 Unless otherwise stated, reactions were carried out under ambient conditions. Light 
sensitive compounds were protected from light using aluminum foil and under low ambient light, 
or with an appropriate safelight. Commercially available reagents were obtained from Sigma 
Aldrich, AK Scientific, Alfa Aesar, or Acros Organics and used without further purification. 
Solvents used for photolysis and UV-vis were omnisolve grade. Other solvents were used as 
received or dried by elution through activated alumina where noted. If a photoproduct was found 
to be unstable to hydrolysis, methanol was distilled from magnesium. Thin-layer 
chromatography using EMD/Merck silica gel 60 F254 pre-coated plates (0.25 mm) was used to 
monitor reactions.  Silica gel chromatography was conducted as described by Still et al. (W. C. 
Still, M. Kahn, A. Mitra, J. Org. Chem. 1978, 43, 2923), with silica gel purchased from Alfa 
Aesar (60 Å, 230-400 mesh). NMR spectra were recorded on Varian (300, 400, 500, or 600 
MHz), or Bruker (400 MHz) spectrometers. HRMS (ESI) were obtained with an Agilent 6200 
Series TOF. UV-vis spectra were recorded on a Cary 60 spectrometer. Samples were irradiated 
with a M455L3 (455 nm, 900 mW), or a M565L3 (565 nm, 880 mW) mounted LED purchased 
from Thor Labs. Photolysis was conducted inside the UV-vis spectrometer cavity or side on 
through a glass flask or NMR tube in air-equilibrated methanol, methanol-d4. Deuterated thiols 
were prepared from thiourea and the appropriate alkyl bromide or iodide following literature 
procedures (J.-F.; d’Orchymont, H. J. Org. Chem. 1982, 47, 2882– 2886). 
 
Preparative Procedures and Spectroscopic Data 
 
Preparation of sulfide-substituted benzoquionones (1a-1n). Both procedures start from ethyl 
3-(4-bromo-2,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-3-methylbutanoate, prepared as 
previously reported.1  
 
General Procedure A: In a 50 mL round bottom flask equipped with a magnetic stir bar and 
rotected from light was dissolved the bromoquinone (1 eq, 0.1 M) in methanol.  To this solution 
is then sequentially added the thiol (1.1 eq) and K2CO3 (1.1 eq).  The reaction was stirred until 
starting material was completely consumed as determined by TLC or LCMS (~ 15 mins), then 1 
equivalent of acetic acid was added to neutralize the base, and the solvent was removed.  The 
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crude was taken up in a small amount of CH2Cl2, then diluted in hexanes and filtered through a 
cotton plug to remove inorganic salts before purification by flash column chromatography (SiO2, 
0 – 10% EtOAc in hexanes) to yield 1 as a yellow solid or oil in > 95% yield. 
 
General Procedure B: In a 20 mL vial equipped with a magnetic stir bar and protected from light 
was dissolved the bromoquinone (1 eq, 0.1M) in 1:1 dichloromethane/water.  To the biphasic 
mixture was added tetrabutylammonium bromide (0.05 eq) and either the thiol (2 eq) and K2CO3 
(2 eq) or the sodium salt of the thiolate (2 eq).  The solution was stirred or shaken vigorously for 
5 minutes, then diluted in water and extracted with dichloromethane (x 3).  The combined 
organics are dried over MgSO4 and concentrated in vacuo.  The crude was purified by flash 
column chromatography (SiO2, 0 – 10% EtOAc in hexanes) to yield 1 as a yellow solid or oil. 
ethyl-3-[2,5-dimethyl-4-(methylsulfanyl)-3,6-dioxocyclohexa-1,4-dien-1-yl]-3-
methylbutanoate (1a).  Prepared according to General Procedure B.  1H NMR (300 MHz, 
Chloroform-d) δ 4.03 (q, J = 7.1 Hz, 2H), 2.95 (s, 2H), 2.47 (s, 2H), 2.16 (s, 3H), 2.13 (s, 2H), 
1.42 (s, 6H), 1.19 (t, J = 7.1 Hz, 2H).  13C NMR (101 MHz, CDCl3) δ 188.26, 183.32, 172.70, 
152.99, 146.36, 141.61, 139.54, 60.26, 47.62, 38.12, 28.64, 17.09, 14.64, 14.51, 14.18. HRMS 
(ESI) calculated for C16H23O4S [M+H]
+ 311.1312, found 311.1316. 
ethyl-3-{2,5-dimethyl-4-[(²H₃)methylsulfanyl]-3,6-dioxocyclohexa-1,4-dien-1-yl}-3-
methylbutanoate (1a-d3).  Prepared according to General Procedure A. 
1H NMR (600 MHz, 
Chloroform-d) δ 4.03 (q, J = 7.1 Hz, 2H), 2.94 (s, 2H), 2.16 (s, 3H), 2.12 (s, 3H), 1.42 (s, 6H), 
1.19 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 188.25, 183.34, 172.70, 152.99, 146.30, 
141.60, 139.54, 77.23, 60.27, 47.63, 38.14, 28.65, 14.64, 14.52, 14.19.  ESI-MS(+) calculated for 
C16H19D3NaO4S [M+Na]
+ 336.1, found  336.0.  HRMS (ESI) calculated for C16H20D3O4S 
[M+H]+ 314.1500, found 314.500.  
ethyl-3-[4-(ethylsulfanyl)-2,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl]-3-
methylbutanoate (1b).  Prepared according to General Procedure A. 1H NMR (600 MHz, 
Chloroform-d) δ 4.02 (q, J = 7.1 Hz, 2H), 3.00 (d, J = 7.5 Hz, 2H), 2.94 (s, 2H), 2.16 (s, 3H), 
2.14 (s, 3H), 1.42 (s, 6H), 1.23 (d, J = 7.4 Hz, 3H), 1.18 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, 
cdcl3) δ 188.45, 183.64, 172.57, 153.11, 148.02, 140.31, 139.49, 60.24, 47.64, 38.20, 28.69, 
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28.11, 15.47, 14.93, 14.57, 14.19. HRMS (ESI) calculated for C17H25O4S [M+H]
+ 325.1468, 
found 325.1468. 
ethyl-3-[2,5-dimethyl-3,6-dioxo-4-(propan-2-ylsulfanyl)cyclohexa-1,4-dien-1-yl]-3-
methylbutanoate (1c).  Prepared according to General Procedure A.  1H NMR (400 MHz, 
Chloroform-d) δ 4.02 (q, J = 7.1 Hz, 2H), 3.77 (p, J = 6.7 Hz, 1H), 2.94 (s, 2H), 2.17 (d, J = 2.9 
Hz, 6H), 1.44 (s, 6H), 1.25 (d, J = 6.7 Hz, 6H), 1.18 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ 188.78, 183.92, 172.46, 153.26, 149.56, 140.00, 139.41, 60.22, 47.62, 38.21, 37.96, 
28.69, 23.81, 15.19, 14.59, 14.19.  HRMS (ESI) calculated for C18H27O4S [M+H]
+ 339.1625, 
found  339.1621. 
 
ethyl-3-[4-(tert-butylsulfanyl)-2,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl]-3-
methylbutanoate (1d).  Prepared according to General Procedure A.  1H NMR (400 MHz, 
Chloroform-d) δ 4.03 (q, J = 7.1 Hz, 2H), 2.93 (s, 2H), 2.29 (s, 3H), 2.20 (s, 3H), 1.44 (s, 6H), 
1.33 (s, 9H), 1.19 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 190.00, 184.92, 172.56, 
156.68, 153.56, 139.13, 137.70, 60.22, 49.74, 47.39, 37.99, 31.94, 29.71, 28.45, 22.71, 16.59, 
14.86, 14.21. HRMS (ESI) calculated for C19H29O4S
 [M+H]+ 353.1781, found 353.1785.  
 
ethyl-3-[4-(benzylsulfanyl)-2,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl]-3-
methylbutanoate (1e).  Prepared according to General Procedure A.  1H NMR (300 MHz, 
Chloroform-d) δ 7.36 – 7.14 (m, 5H), 4.18 (s, 2H), 3.98 (q, J = 7.1 Hz, 2H), 2.90 (s, 2H), 2.16 (s, 
3H), 2.00 (s, 3H), 1.40 (s, 6H), 1.14 (t, J = 7.1 Hz, 3H).  13C NMR (126 MHz, cdcl3) δ 188.50, 
183.71, 172.44, 153.14, 149.22, 139.47, 139.40, 137.76, 129.01, 128.52, 127.24, 60.21, 47.53, 
38.19, 38.16, 28.62, 14.86, 14.59, 14.18.  HRMS (ESI) calculated for C22H27O4S [M+H]
+ 
387.1625, found  387.1632.  
 
ethyl-3-(2,5-dimethyl-3,6-dioxo-4-{[phenyl(²H₂)methyl]sulfanyl}-cyclohexa-1,4-dien-1-yl)-3-
methylbutanoate (1e-d2).  Prepared according to General Procedure A.  
1H NMR (400 MHz, 
Chloroform-d) δ 7.46 – 6.99 (m, 5H), 4.00 (q, J = 7.1 Hz, 2H), 2.92 (s, 2H), 2.18 (s, 3H), 2.03 (s, 
3H), 1.42 (s, 6H), 1.16 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 188.48, 183.71, 
172.44, 153.12, 149.13, 139.47, 139.38, 137.63, 128.98, 128.51, 127.24, 60.20, 47.51, 38.15, 
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37.61 (quintet, CD2), 28.61, 14.84, 14.58, 14.17. HRMS (ESI) calculated for C22H25D2O4S 
[M+H]+ 389.1750, found 389.1751. 
ethyl-3-(4-{[(4-methoxyphenyl)methyl]sulfanyl}-2,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-
1-yl)-3-methylbutanoate (1f).  Prepared according to General Procedure A.  1H NMR (300 
MHz, Chloroform-d) δ 7.17 (d, J = 8.6 Hz, 2H), 6.80 (d, J = 8.6 Hz, 2H), 4.15 (s, 2H), 3.99 (q, J 
= 7.1 Hz, 2H), 3.77 (s, 3H), 2.91 (s, 2H), 2.16 (s, 3H), 2.02 (s, 3H), 1.41 (s, 6H), 1.19 – 1.10 (m, 
3H). 13C NMR (126 MHz, cdcl3) δ 188.51, 183.74, 172.46, 158.79, 153.10, 148.84, 139.79, 
139.40, 130.17, 129.72, 113.92, 77.27, 77.01, 76.76, 60.20, 55.23, 47.55, 38.16, 37.73, 28.64, 
14.86, 14.60, 14.17, 0.01.  HRMS (ESI) calculated for C23H29O5S [M+H]
+ 417.1730, found  
421.417.1602. 
 
ethyl-3-(4-{[(4-chlorophenyl)methyl]sulfanyl}-2,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-1-
yl)-3-methylbutanoate (1g).  Prepared according to General Procedure A.  1H NMR (300 MHz, 
Chloroform-d) δ 7.24 – 7.14 (m, 4H), 4.13 (s, 2H), 4.00 (q, J = 7.2 Hz, 2H), 2.90 (s, 2H), 2.15 (s, 
3H), 2.01 (s, 3H), 1.40 (s, 6H), 1.16 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, cdcl3) δ 188.47, 
183.61, 172.47, 153.52, 149.81, 139.18, 138.79, 136.39, 133.01, 130.34, 128.69, 77.29, 77.03, 
76.78, 60.24, 47.50, 38.11, 37.41, 28.53, 14.95, 14.57, 14.19.  HRMS (ESI) calculated for  
calculated for C22H26ClO4S [M+H]
+ 421.1235, found  421.1180.  
ethyl-3-(2,5-dimethyl-4-{[(4-nitrophenyl)methyl]sulfanyl}-3,6-dioxocyclohexa-1,4-dien-1-
yl)-3-methylbutanoate (1h).  Prepared according to General Procedure A.  1H NMR (500 MHz, 
Chloroform-d) δ 8.23 – 8.10 (m, 2H), 7.43 – 7.32 (m, 2H), 4.21 (s, 2H), 3.99 (q, J = 7.1 Hz, 2H), 
2.89 (s, 2H), 2.15 (s, 3H), 1.98 (s, 3H), 1.39 (s, 6H), 1.17 (t, J = 7.1 Hz, 3H). 13C NMR (126 
MHz, cdcl3) δ 188.41, 183.41, 172.57, 154.21, 151.03, 146.99, 145.62, 138.82, 137.59, 129.75, 
123.83, 60.25, 47.42, 37.96, 37.31, 28.32, 15.05, 14.56, 14.16. ESI-MS(+) calculated for 
C22H25NNaO6S [M+Na]+ 454.1, found 454.1. 
ethyl-3-{4-[(2-methoxy-2-oxoethyl)sulfanyl]-2,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-1-
yl}-3-methylbutanoate (1i).  Prepared according to General Procedure A.  1H NMR (600 MHz, 
Chloroform-d) δ 4.02 (q, J = 7.4 Hz, 2H), 3.73 (s, 2H), 3.70 (s, 3H), 2.92 (s, 2H), 2.15 (s, 6H), 
1.42 (q, J = 7.6 Hz, 6H), 1.18 (t, J = 7.0 Hz, 3H). 13C NMR (126 MHz, cdcl3) δ 188.26, 183.29, 
172.55, 169.83, 153.33, 148.90, 139.55, 138.07, 60.28, 52.51, 47.55, 38.19, 34.65, 28.60, 14.92, 
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14.58, 14.19.  ESI-MS(+) calculated for [C18H24NaO6S]
+ ([M+Na]+) 391.1, found  391.0. HRMS 
(ESI) calculated for C18H25O6S [M+H]
+ 369.1366, found  369.1385.  
ethyl-3-{4-[(4-hydroxybutyl)sulfanyl]-2,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl}-3-
methylbutanoate (1j).  Prepared according to General Procedure B in 43% yield.  1H NMR 
(300 MHz, Chloroform-d) δ 4.02 (q, J = 7.2 Hz, 2H), 3.68 – 3.58 (m, 2H), 3.05 – 2.96 (m, 2H), 
2.94 (s, 2H), 2.17 (s, 3H), 2.15 (s, 3H), 1.70 – 1.62 (m, 4H), 1.42 (s, 6H), 1.19 (t, J = 7.1 Hz, 
3H). 13C NMR (126 MHz, cdcl3) δ 188.42, 183.54, 172.92, 153.45, 148.09, 140.45, 139.31, 
62.29, 60.38, 47.65, 38.13, 33.41, 31.48, 28.58, 26.78, 14.91, 14.53, 14.16.  ESI-MS(+) 
calculated for [C19H28NaO5S]
+ ([M+Na]+) 391.1, found  391.1. HRMS (ESI) calculated for 
C19H29O5S [M+H]
+ 369.1730, found  369.1740. 
 
ethyl-3-[4-(hex-5-en-1-ylsulfanyl)-2,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl]-3-
methylbutanoate (1k).  Prepared according to General Procedure A.  1H NMR (500 MHz, 
Chloroform-d) δ 5.76 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.02 – 4.94 (m, 1H), 4.95 – 4.89 (m, 1H), 
4.01 (q, J = 7.1 Hz, 2H), 2.97 (dd, J = 7.7, 6.8 Hz, 2H), 2.93 (s, 2H), 2.15 (s, 3H), 2.13 (s, 3H), 
2.08 – 2.00 (m, 2H), 1.60 – 1.52 (m, 2H), 1.51 – 1.43 (m, 2H), 1.41 (s, 6H), 1.17 (t, J = 7.1 Hz, 
3H).  13C NMR (126 MHz, cdcl3) δ 188.41, 183.59, 172.54, 153.11, 147.83, 140.53, 139.47, 
138.35, 114.73, 60.21, 47.61, 38.18, 33.64, 33.20, 29.7s6, 28.67, 27.80, 14.93, 14.57, 14.19.  
ESI-MS(+) calculated for C21H30NaO4S
+ ([M+Na]+) 401.1, found  401.2.  HRMS (ESI) 
calculated for C21H31O4S
+ [M+H]+ 379.1938, found  379.1948. 
 
ethyl-3-{4-[(cyclopropylmethyl)sulfanyl]-2,5-dimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl}-3-
methylbutanoate (1l).  Prepared according to General Procedure A in 54% yield.  1H NMR 
(300 MHz, Chloroform-d) δ 3.99 (q, J = 7.1 Hz, 1H), 2.91 (s, 2H), 2.88 (d, J = 7.3 Hz, 2H), 2.14 
(s, 6H), 1.40 (s, 6H), 1.15 (t, J = 7.2 Hz, 3H), 1.04 – 0.82 (m, 1H), 0.64 – 0.38 (m, 2H), 0.24 – 
0.11 (m, 2H). 13C NMR (126 MHz, cdcl3) δ 188.52, 183.73, 172.57, 153.18, 147.88, 140.74, 
139.43, 60.23, 47.62, 39.67, 38.17, 28.68, 14.95, 14.58, 14.19, 11.76, 5.59.  ESI-MS(+) 
calculated for C19H26NaO4S [M+Na]
+ 373.1, found  373.1.  HRMS (ESI) calculated for 
C19H27O4S [M+H]
+ 351.1625, found  351.1650. 
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ethyl-3-[2,5-dimethyl-3,6-dioxo-4-({[(1R,2R)-2-phenylcyclopropyl]methyl}sulfanyl)-
cyclohexa-1,4-dien-1-yl]-3-methylbutanoate (1m).  Prepared according to General Procedure 
A. 1H NMR (400 MHz, Chloroform-d) δ 7.22 (dd, J = 7.7, 7.2 Hz, 2H), 7.14 (t, J = 7.2 Hz, 1H), 
7.02 (d, J = 7.7 Hz, 2H), 4.01 (q, J = 7.0 Hz, 2H), 3.21 – 3.00 (m, 2H), 2.93 (q, J = 16.1 Hz, 2H), 
2.16 (s, 3H), 2.13 (s, 3H), 1.89 – 1.69 (m, 1H), 1.42 (d, J = 3.5 Hz, 6H), 1.36 – 1.23 (m, 1H), 
1.18 (t, J = 7.0 Hz, 3H), 1.09 – 0.96 (m, 1H), 0.95 – 0.84 (m, 1H). ESI-MS(+) calculated for 
C25H30NaO4S [M+Na]
+ 449.1, found  449.2.  
ethyl-3-{2,5-dimethyl-3,6-dioxo-4-[(1-phenylethyl)sulfanyl]cyclohexa-1,4-dien-1-yl}-3-
methylbutanoate (1n).  Prepared according to General Procedure A.  1H NMR (300 MHz, 
Chloroform-d) δ 7.24 – 7.13 (m, 5H), 4.79 (q, J = 7.1 Hz, 1H), 4.04 – 3.87 (m, 2H), 2.86 (s, 2H), 
2.11 (s, 3H), 2.01 (s, 3H), 1.61 (d, J = 7.0 Hz, 3H), 1.37 (d, J = 9.8 Hz, 6H), 1.13 (t, J = 7.1 Hz, 
3H). 13C NMR (126 MHz, cdcl3) δ 188.78, 184.01, 172.26, 152.97, 150.17, 143.06, 139.47, 
139.33, 128.42, 127.38, 127.26, 77.28, 77.03, 76.78, 60.15, 47.44, 46.46, 38.17, 28.65, 22.40, 
14.98, 14.57, 14.21. ESI-MS(+) calculated for C23H28NaO4S [M+Na]
+ 423.1, found  423.0.  
HRMS (ESI) calculated for C23H29O4S
+ [M+H]+ 401.1781, found 401.1778. 
3-methyl-3-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)butanoic acid (6). 6-hydroxy-
4,4,5,7,8-pentamethylchroman-2-one was prepared according to literature (J. Am. Chem. 
Soc., 2006, 128 (29), 9518–9525) procedure from 2,3,5-trimethylhydroquinone and 3,3-
dimethylacrylic acid in 84% yield. 1H NMR (500 MHz, Chloroform-d) δ 4.98 (s, 1H), 2.54 (s, 
2H), 2.36 (s, 2H), 2.21 (s, 3H), 2.18 (s, 3H), 1.45 (s, 6H). 13C NMR (126 MHz, cdcl3) δ 169.09, 
148.90, 143.42, 128.15, 123.37, 122.05, 119.11, 46.04, 35.45, 27.70, 27.69, 14.51, 12.55, 
12.33.The crude lactone was oxidized with N-bromosuccinamide in acetonitrile / water to yield 
the quinone acid as a yellow solid in 88% yield. 1H NMR (500 MHz, Chloroform-d) δ 3.01 (s, 
2H), 2.14 (s, 3H), 1.95 (q, J = 1.1 Hz, 3H), 1.92 (q, J = 1.1 Hz, 3H), 1.43 (s, 6H). 13C NMR (126 
MHz, cdcl3) δ 190.85, 187.42, 178.84, 152.02, 142.97, 139.00, 138.37, 47.28, 37.91, 28.77, 
14.31, 12.50, 12.11. 
 
ethyl 3-methyl-3-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)butanoate (6). 3-methyl-
3-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)butanoic acid (2.6 g, 10 mmol) and ethanol 
(12 mL, 205 mmol) were dissolved in CH2Cl2 (25 mL) and the resulting solution was cooled to 0 
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°C. N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (2.36 g, 12.3 mmol) and 4-
(Dimethylamino)pyridine (195 mg, 1.6 mmol) were added in one portion, and the solution was 
stirred for 15 min at  to 0 °C before allowing to warm to room temperature. The solvent was then 
removed, and the crude product was purified on silica (SiO2, 10% EtOAc / hexanes). 
1H NMR 
(400 MHz, Chloroform-d) δ 4.03 (q, J = 7.1 Hz, 2H), 2.96 (s, 2H), 2.14 (s, 3H), 1.97 (s, 6H), 
1.43 (s, 6H), 1.18 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 190.90, 187.47, 172.78, 
152.75, 143.11, 138.52, 138.30, 60.20, 47.68, 38.13, 28.74, 14.27, 14.17, 12.65, 12.14. HRMS 
(ESI) calculated for C16H23O4
 [M+H]+ 279.1591, found 279.1593. 
 
Preparative-Scale Photolysis 
 In a round-bottom flask equipped with a magnetic stir bar was dissolved 1a (10-15 mg) in 
air-equilibrated dry methanol (20 mL).  The solution was irradiated with focused light from a 
420 nm LED until the solution was colorless or the starting material was completely consumed 
determined by TLC analysis.  The sample was then concentrated in vacuo to yield the products 2, 
3, or 4, unless otherwise stated.  If a mixture was obtained, the crude was purified by flash 
column chromatography (SiO2, 10%-25% EtOAc in hexanes) to yield the isolated products. All 
reported yields are based on integration of the crude NMR spectrum. 
 
6-hydroxy-7-[(6-hydroxy-4,4,5,8-tetramethyl-2-oxo-3,4-dihydro-2H-1-benzopyran-7-
yl)disulfanyl]-4,4,5,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-one (4).  1H NMR (300 
MHz, Chloroform-d) δ 6.46 (s, 2H), 2.56 (s, 4H), 2.31 (s, 6H), 2.13 (s, 6H), 1.47 (s, 12H).  13C 
NMR (101 MHz, CDCl3) δ 167.83, 152.80, 143.26, 135.37, 128.73, 120.10, 118.08, 45.58, 
36.00, 27.39, 14.87, 14.40. HRMS (ESI) calculated for C26H29O6S2
 [M-H]- 501.1411, found 
501.1408. 
 
6-hydroxy-7-((methoxymethyl)thio)-4,4,5,8-tetramethylchroman-2-one (2a). Photolysis of 1a 
produces 2a (99%). 1H NMR (400 MHz, Chloroform-d) δ 7.17 (s, 1H), 4.69 (s, 2H), 3.48 (s, 
3H), 2.55 (s, 2H), 2.50 – 2.42 (m, 3H), 2.41 – 2.35 (m, 3H), 1.46 (s, 6H).  13C NMR (101 MHz, 
cdcl3) δ 168.23, 152.64, 143.19, 132.95, 128.26, 119.73, 117.69, 79.56, 57.43, 45.75, 35.80, 
27.43, 15.06, 15.02.  HRMS (ESI) calculated for C15H19O4S
 [M-H]- 295.1010, Found 295.1009. 
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6-hydroxy-7-((methoxymethyl-d2)thio)-4,4,5,8-tetramethylchroman-2-one (2a-d2). 
Photolysis of 1a-d2 produced 2a-d2 quantitatively. 
1H NMR (400 MHz, Chloroform-d) δ 7.18 (s, 
1H), 3.48 (s, 3H), 2.56 (s, 2H), 2.45 (d, J = 0.7 Hz, 3H), 2.40 – 2.37 (m, 3H), 1.46 (s, 6H). 13C 
NMR (101 MHz, CDCl3) δ 168.29, 152.64, 143.20, 132.95, 128.29, 119.73, 117.62, 57.35, 
45.75, 35.81, 27.44, 15.10, 15.05. HRMS (ESI) calculated for C15H17D2O4S [M-H]
- 297.1135, 
found 297.1136. 
 
6-hydroxy-7-[(1-methoxyethyl)sulfanyl]-4,4,5,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-
2-one (2b).  Photolysis of 1b produces 2b quantitatively.  1H NMR (500 MHz, Chloroform-d) δ 
7.38 (s, 1H), 4.68 (q, J = 6.2 Hz, 1H), 3.52 (s, 3H), 2.58 (s, 2H), 2.45 (d, J = 0.7 Hz, 3H), 2.40 
(d, J = 0.7 Hz, 3H), 1.48 (d, J = 2.0 Hz, 6H), 1.44 (d, J = 6.2 Hz, 3H).  13C NMR (126 MHz, 
cdcl3) δ 168.30, 153.25, 143.23, 132.95, 128.93, 119.62, 115.48, 87.50, 56.74, 45.81, 35.83, 
27.57, 27.42, 21.80, 15.31, 15.07. HRMS (ESI) calculated for C16H21O4S [M-H]
- 309.1166, 
found 309.1171. 
 
6-hydroxy-7-[(2-methoxypropan-2-yl)sulfanyl]-4,4,5,8-tetramethyl-3,4-dihydro-2H-1-
benzopyran-2-one (2c).  Photolysis of 1c produces 2c quantitatively, however hydrolysis of 5c 
to 7 was observed if the solvent was not removed immediately after completion of photolysis. 1H 
NMR (400 MHz, Chloroform-d) δ 7.57 (s, 1H), 3.49 (s, 3H), 2.56 (s, 2H), 2.42 (s, 3H), 2.38 (s, 
3H), 1.52 (s, 6H), 1.47 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 168.37, 153.59, 143.12, 132.91, 
129.17, 119.56, 116.81, 91.75, 51.05, 45.81, 35.80, 27.65, 27.48, 15.46, 15.05. HRMS (ESI) 
calculated for C17H23O4S [M-H]
- 323.1323, found 323.1324.  
 
6-hydroxy-7-{[methoxy(phenyl)methyl]sulfanyl}-4,4,5,8-tetramethyl-3,4-dihydro-2H-1-
benzopyran-2-one (2e). Photolysis of 1e produces 2e (85%).  1H NMR (400 MHz, Chloroform-
d) δ 7.44 (s, 1H), 7.35 – 7.15 (m, 5H), 5.47 (s, 1H), 3.44 (s, 3H), 2.54 (s, 2H), 2.34 (s, 3H), 2.27 
(s, 3H), 1.46 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 168.33, 153.63, 142.99, 137.78, 133.24, 
129.10, 128.63, 128.34, 125.88, 119.64, 116.33, 92.23, 57.64, 45.81, 35.81, 27.56, 27.37, 15.01. 
HRMS (ESI) calculated for C21H23O4S
 [M-H]- 371.1323, found 371.1327. 
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6-hydroxy-7-((methoxy(phenyl)methyl-d)thio)-4,4,5,8-tetramethylchroman-2-one (2e-d2). 
Photolysis of 1e-d2 produces 2e-d2 (85%). 
1H NMR (400 MHz, Chloroform-d) δ 7.43 (s, 1H), 
7.32 – 7.27 (m, 3H), 7.26 – 7.19 (m, 2H), 3.44 (s, 3H), 2.54 (s, 2H), 2.42 – 2.30 (m, 3H), 2.27 (d, 
J = 0.7 Hz, 3H), 1.46 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 168.33, 153.63, 142.98, 137.72, 
133.24, 129.09, 128.63, 128.34, 125.87, 119.63, 116.30, 57.59, 45.81, 35.81, 27.56, 27.37, 15.01. 
HRMS (ESI) calculated for C21H22DO4S [M-H]
- 372.1385, found 372.1390. 
 
Photolysis of 1f produces 6f (64%) and 7 (36%).  5-(4-methoxyphenyl)-2,8,13,13-tetramethyl-
4,10-dioxa-6-thiatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-trien-11-one (6f).  1H NMR (300 MHz, 
Chloroform-d) δ 7.54 (d, J = 8.7 Hz, 2H), 7.06 – 6.78 (m, 3H), 3.83 (s, 3H), 2.55 (s, 2H), 2.32 (s, 
3H), 2.18 (s, 3H), 1.43 (s, 6H). 
 
Photolysis of 1j produces 2j and 6 in a ratio of 17:83. 6-hydroxy-4,4,5,8-tetramethyl-7-
(oxolan-2-ylsulfanyl)-3,4-dihydro-2H-1-benzopyran-2-one (6).  1H NMR (500 MHz, 
Chloroform-d) δ 7.56 (s, 1H), 5.29 (dd, J = 6.9, 4.3 Hz, 1H), 4.09 – 4.00 (m, 1H), 3.99 – 3.91 (m, 
1H), 2.55 (d, J = 1.3 Hz, 2H), 2.45 (d, J = 0.6 Hz, 3H), 2.39 (d, J = 0.7 Hz, 3H), 2.38 – 2.31 (m, 
1H), 2.12 – 1.98 (m, 2H), 1.96 – 1.85 (m, 1H), 1.46 (d, J = 4.9 Hz, 6H). 13C NMR (126 MHz, 
Chloroform-d) δ 168.37, 153.22, 143.15, 132.97, 128.57, 119.83, 117.21, 88.55, 68.19, 45.81, 
35.84, 32.75, 27.57, 27.37, 25.13, 15.13, 15.07.  Although an analytically pure sample of 2j 
could not be obtained due to decomposition while carrying out standard purification techniques, 
the yield was estimated by integration of diagnostic peaks in the 1H-NMR spectrum 
(R(OCH3)SC-H) and the identity established by LC-MS analysis of the crude reaction mixture.  
6-hydroxy-7-[(4-hydroxy-1-methoxybutyl)sulfanyl]-4,4,5,8-tetramethyl-3,4-dihydro-2H-1-
benzopyran-2-one (2j). 1H NMR (300 MHz, Chloroform-d) δ 4.52 (t, J = 6.1 Hz, 1H), 3.51 (s, 
3H).    ESI-MS(+) calculated for C18H26NaO5S [M+Na]
+ 377.1, found  377.1. 
 
6-hydroxy-7-[(1-methoxyhex-5-en-1-yl)sulfanyl]-4,4,5,8-tetramethyl-3,4-dihydro-2H-1-
benzopyran-2-one (2k).  Photolysis of 1k produces 2k.  1H NMR (400 MHz, Chloroform-d) δ 
7.43 (s, 1H), 5.74 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.05 – 4.89 (m, 2H), 4.48 (dd, J = 7.6, 5.2 
Hz, 1H), 3.49 (s, 3H), 2.56 (s, 2H), 2.44 (s, 3H), 2.38 (s, 3H), 2.10 – 1.96 (m, 2H), 1.83 – 1.62 
(m, 2H), 1.56 – 1.49 (m, 2H), 1.47 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 168.32, 153.10, 
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143.21, 137.99, 132.77, 128.56, 119.65, 116.06, 115.03, 91.76, 57.01, 45.80, 35.81, 35.04, 33.11, 
27.53, 27.44, 25.20, 15.26, 15.06.  
 
Photolysis of 1l produces 2l.  7-{[cyclopropyl(methoxy)methyl]sulfanyl}-6-hydroxy-4,4,5,8-
tetramethyl-3,4-dihydro-2H-1-benzopyran-2-one (1l).  1H NMR (400 MHz, Chloroform-d) δ 
7.43 (s, 1H), 3.94 (d, J = 8.0 Hz, 1H), 3.50 (s, 3H), 2.56 (s, 2H), 2.47 (s, 3H), 2.38 (s, 3H), 1.46 
(d, J = 1.7 Hz, 6H), 1.18 – 1.02 (m, 1H), 0.69 – 0.54 (m, 2H), 0.53 – 0.44 (m, 1H), 0.40 – 0.32 
(m, 1H).  13C NMR (101 MHz, CDCl3) δ 168.35, 153.38, 143.12, 132.87, 129.01, 119.40, 
116.12, 94.99, 56.82, 45.81, 35.81, 27.54, 27.44, 15.98, 15.33, 15.06, 5.41, 3.91. Note: NMR of 
5l contains 7 as an impurity as a result of thermal decomposition after purification.  
 
Photolysis of 1m produces the diastereomers 6-hydroxy-7-((1-methoxy-2-phenylcyclo-
propyl)thio)-4,4,5,8-tetramethylchroman-2-one (4m) in a 3:2 ratio, along with other 
uncharacterized byproducts.  Although isolation proved difficult due to decomposition, 
assignment has been made primarily based on clear 1H-NMR resonances for the cyclopropane -
CH, oxidized methylene -CH, methyl ether -OCH3, aryl -CH3, and the lactone methylene -CH2 
protons.   4m: 1H NMR (400 MHz, Chloroform-d) δ 4.41 (d, J = 5.8 Hz, 1H), 3.53 (s, 3H), 2.47 
(s, 2H), 2.42 (s, 3H), 2.29 (s, 3H). Second product: 1H NMR (400 MHz, Chloroform-d) δ 4.31 
(d, J = 7.0 Hz, 1H), 3.55 (s, 3H), 2.51 (s, 2H), 2.39 (s, 3H), 2.26 (s, 3H).  
 
Photolysis of 6. An approximately 1.5 mM solution of 6 was irradiated with a focused 420 nm 
LED in methanol with continuous argon sparging until complete consumption of starting 
material was observed by TLC. The solvent was removed under reduced pressure to yield, by 
NMR analysis, a mixture of products resulting from H-atom abstraction from the t-butyl group 
followed by a known rearrangement. An illustrative compound, 5-hydroxy-4,6,7-trimethyl-3-
(prop-1-en-2-yl)benzofuran-2(3H)-one (10), was isolated from the mixture by silica gel 
chromatography followed by recrystallization, and fully characterized. 1H NMR (600 MHz, 
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Chloroform-d) δ 5.13 (p, J = 1.5 Hz, 1H), 5.03 (q, J = 0.9 Hz, 1H), 4.45 (s, 1H), 4.30 (s, 1H), 
2.22 (s, 3H), 2.20 (s, 3H), 2.10 (s, 3H), 1.69 (dd, J = 1.5, 0.8 Hz, 3H). 13C NMR (126 MHz, 
cdcl3) δ 175.70, 148.62, 146.32, 138.73, 123.28, 121.51, 118.45, 117.63, 116.90, 52.97, 19.66, 
12.29, 12.07, 11.73. HRMS (ESI) calculated for C14H15O3
 [M-H]- 231.1027, found 231.1018. 
 
Quantum Yield Measurements  
Materials and Methods 
 All chemicals and solvents were purchased in the highest grade available.  Spectral grade 
methanol was distilled prior to use for quantum yield measurements. Thioxanthone was purified 
by preparative HPLC using a 5-95% acetonitrile-water gradient, and pure fractions were used for 
measurement of sensitized quantum yields.  Diethylaniline was distilled under vacuum 
immediately prior to use. Samples were prepared in eight-inch NMR tubes (Wilmad WG-1000) 
and photolyzed in a custom-made merry-go-round apparatus rotating at 20 rpm using diffuse 
light from a 1 watt LED centered at 420 nm (Thorlabs M420L3), powered with approximately 1 
amp.  All procedures were carried out in darkness with a red safety-light.  Data were collected on 
an Agilent 1260 HPLC equipped with a diode-array detector using a 60% isocratic acetonitrile-
water (+ 0.1% AcOH) elution.  Absorbance spectra were recorded on a Cary 60 using cuvettes 
with a 10 mm path-length. 
 
Preparation of Potassium Ferrioxalate 
 The following procedure44 is taken from Photochemistry of Organic Compounds by Klan 
& Wirz and is performed in a dark room with a red safety-light.  In an Erlenmeyer flask with 
magnetic stir-bar is mixed 1.5 M potassium oxalate monohydrate (300 mL) and 1.5 M ferric 
chloride hexahydrate (100 mL).  The mixture is stirred 10 minutes then filtered using a Büchner 
funnel.  The collected solid is recrystallized three times from warm water, filtered, and dried over 
a current of warm air overnight to provide crystalline potassium ferrioxalate trihydrate, which is 
stored at room temperature in the dark. 
 
General procedure for Ferrioxalate actinometry 
 Solutions of potassium ferrioxalate and 1,10-phenanthroline are always made fresh when 
measuring quantum yields.  Solid potassium ferrioxalate trihydrate (60 mg) is weighed into a 
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tared 20 mL vial to which is then added 0.05 M H2SO4 (20 mL).  The mixture is thoroughly 
shaken to ensure a homogenous solution is formed.  Additionally, a solution of 1,10-
phenanthroline (40 mg) in 1M sodium acetate buffer (20 mL; prepared by adding 82 g of 
NaOAc•3H2O and 10 mL H2SO4 to 1 L of water) is prepared, and again thoroughly shaken until 
the solid is completely dissolved. 
 Using a 1 mL gas-tight syringe fitted with a four-inch needle, 500 L of actinometer 
solution is transferred to the bottom of an NMR tube and capped.  The solution is irradiated at 
420 nm in the merry-go-round apparatus.  Upon completion, 100 L of the photolysate is 
transferred to a 2 mL volumetric flask (the syringe is initially flushed three times with a small 
volume of photolysate). 800 L of buffered phenanthroline solution is added and the flask is 
diluted with deionized water to the mark.  The solution is allowed to develop for 15 minutes, 
then transferred via pipette to a clean dry cuvette and the UV/Vis spectrum recorded. 
 
General procedures for photolysis quantum yields 
 Sample preparation for direct photolysis. Into an amber HPLC vial is transferred 1 mL 
of a solution of 1 in methanol that is adjusted to a concentration such that the 10 mm absorbance 
at 420 nm is between 0.05 – 0.1.  Using a 1 mL gas-tight syringe fitted with a four-inch needle, 
500 L of the solution is transferred to the bottom of an eight-inch NMR tube, freeze-pump-
thawed three times, then flame-sealed while frozen under vacuum.  The remaining 500 L is 
capped for HPLC analysis. 
 
 Sample preparation for sensitized photolysis.  A stock solution of thioxanthone in 
methanol is initially prepared with a 10 mm absorbance at 420 nm between 0.05 – 0.1 and a total 
volume of 10 mL.  To 5 mL of this solution is added a calculated amount of 1 such that the 10 
mm absorbance of 1 would be 0.1 at 420 nm (determined by HPLC calibration curve).  Using a 1 
mL gas-tight syringe, samples with different concentrations of 1 are prepared in amber HPLC 
vials (1 mL total) by mixing the two stock solutions at different ratios (up to a 10x dilution of 1).  
Using a 1 mL gas-tight syringe fitted with a four-inch needle, 500 L of each solution is 
transferred to the bottom of an eight-inch NMR tube, freeze-pump-thawed three times, then 
flame-sealed under vacuum.  The remaining 500 L is capped for HPLC analysis.  In some 
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cases, the thioxanthone precipitates from the freeze-pump-thawed solution in which case gentle 
agitation results in dissolution.   
 
 Sample preparation for direct photolysis in the presence of quencher.  A stock solution 
of 1 in methanol is initially prepared with a 10 mm absorbance at 420 nm between 0.05 – 0.1 and 
a total volume of 10 mL.  To 5 mL of this solution is added N,N-diethylaniline (80 L) to create 
a second stock solution with a 0.1 M quencher concentration.  Using a 1 mL gas-tight syringe, 
samples with different quencher concentrations (0 – 100 mM) are prepared in amber HPLC vials 
(1 mL total) by mixing the two stock solutions at different ratios.  Using a 1 mL gas-tight syringe 
fitted with a four-inch needle, 500 L of each solution is transferred to the bottom of an eight-
inch NMR tube, freeze-pump-thawed three times, then flame-sealed under vacuum.  The 
remaining 500 L is capped for HPLC analysis. 
 
 Photolysis.  The prepared samples are irradiated in a well-ventilated space using a 420 
nm LED and merry-go-round apparatus that spins at approximately 20 rpm.  Both components 
(the LED and merry-go-round) are mounted on an optical rail to ensure consistency in light 
exposure.  In some cases, the intensity of the LED is adjusted such that total photolysis time is at 
least 5 minutes, which ensures an adequate number of revolutions on the merry-go-round. Upon 
completion, the NMR tubes are scored near the surface of the liquid, cracked, poured into amber 
HPLC vials, and capped for analysis.   
 
 Data collection. In general, quantitative analysis for the photolysis of 1 was performed 
by HPLC using an isocratic elution of 60% acetonitrile in water and integration of the peak 
corresponding to 1 in the 254 nm absorbance trace.  Quantitative analysis for photolysis of 
ferrioxalate was performed by UV/Vis spectroscopy using a glass cuvette (10 mm path length), 
blanked with water, and by measurement of the absorbance at 510 nm corresponding to the Fe2+-
phenanthroline complex. 
 
 Calculation of the quantum yield.  The quantum yield for disappearance of 1 (Φ) due to 
direct photolysis is given by Eq. 1a. 
 Φ =	

	
   (1a) 
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where 
 is the number of moles of 1 consumed, and  is the number moles of photons 
absorbed by 1. 
 is further given by Eq. 1b, the difference between the number of moles pre- 
and post-photolysis, which are calculated from the integrations in the HPLC ,	the use of a 
calibration function (), and the volume of the photolysis sample (). 
 
 =	 
	 − 
	 •   (1b) 
 The value for  is calculated using Eq. 1c, where 1 − 10
 represents the fraction 
of the LED output absorbed by 1, 1 − 10 !"# is that absorbed by potassium ferrioxalate, 
Φ$%& is the quantum yield for Fe
2+ production (1.11544), and 
$%& is the number of moles of 
Fe2+ produced.  The latter is given by the absorbance of the Fe2+-phenanthroline complex 
measured at 510 nm (see general procedure above), the known extinction coefficient (11100 M-
1cm-1), and the photolysis volume.  The fraction of photons absorbed by 1 is given by a 
calibration function (') between 1 − 10 and , which is more convenient than 
measuring the actual absorbance spectrum of the photolysis solution.  For the fraction of photons 
absorbed by the ferrioxalate solution, the absorbance must be measured directly before and after 
photolysis. 
  =
(()*+,-
(()*+,- !"#
•
./01#
/01#
=	
23
(()*+,- !"#
 •
./01#
/01#
 (1c) 
 For calculation of the sensitized quantum yield, 1 − 10 is replaced with the 
fraction of photons absorbed by the sensitizer, which is again given by a calibration function 
between the integration of the thioxanthone peak in the HPLC trace and its UV/Vis absorption 
spectrum.  In some cases, a small amount of direct photolysis occurs during sensitization 
experiments.  To correct for this, the amount of 1 consumed 
 due to direct photolysis is 
subtracted from the total using the known quantum yield (Φ before calculation of the 
sensitized quantum yield is performed.  In most cases, this amount accounted for less than 10% 
of the total consumption of 1.   
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Figure S1. Stern-Volmer quenching of the photolysis of 1a by diethylaniline. 
 
Figure S2. Stern-Volmer quenching of the photolysis of 1a-d3 by diethylaniline. 
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Figure S3. Stern-Volmer quenching of the photolysis of 1b by diethylaniline. 
 
 
Figure S4. Stern-Volmer quenching of the photolysis of 1c by diethylaniline. 
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Figure S5. Stern-Volmer quenching of the photolysis of 1e by diethylaniline. 
 
 
Figure S6. Stern-Volmer quenching of the photolysis of 1e-d2 by diethylaniline. 
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Transient Absorption Spectroscopy. Compounds for study were dissolved in the indicated 
solvent, then diluted to a concentration such that A355 < 0.4. The sample was placed in a four 
sided quartz cuvette (Starna Cells) with a stir bar. This cuvette was open to air for the oxygen-
saturated samples. Air-free samples were subjected to freeze-pump-thaw cycles to remove 
oxygen, before backfilling with argon. A custom cuvette with an auxiliary bulb for freezing, 
connections for Schlenk line maniuplations, and Teflon valve (Kontes) for sealing under high-
vacuum was used for samples void of oxygen.  
 The third harmonic from a Q-switched Nd:YAG laser (SpectraPhysics, Quanta-Ray PRO 
Series) provided 355 nm pulses, 8 ns, at 10 Hz for excitation. A 75 W Xe arc-lamp operated in 
continuous or pulsed mode was passed through the sample colinearly with the excitation pulse 
for single-wavelength transient absorption experiments. A double monochromator selected probe 
wavelengths. Stray light was removed with appropriate short-pass and long-pass filter, while 
intensity was modulated with a neutral density filter. A photomultiplier tube (Hamamatsu R928), 
and amplified using a 200 MHz wideband voltage amplifier (FEMTO, DHPVA-200) was used to 
detect light. Approximately 150 shots were collected at each wavelength, and the data were log-
compressed and then fit with custom scripts in MATLAB (Mathworks). The same laser system 
was used for full-spectrum transient absorption with the modifications of a nanosecond flash 
lamp and diode detector as described elsewhere (Dempsey, J. L.; Winkler, J. R.; Gray, H. B. 
Journal of the American Chemical Society 2010, 132, 1060–1065). 
 
Figure S7. Full-spectrum transient absorption trace 1a in air-equilibrated acetonitrile. 
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Figure S8.  Chiral HPLC traces for the photolysis of enantioenriched 1n where arrows indicate 
the peaks for each enantiomer. a) Racemic mixture of 1n.  b) Single enantiomer isolated by 
HPLC c) Photolysis of the enantiomer indicated by blue arrow to 75% conversion. d) photolysis 
of the enantiomer indicated by the orange arrow to 75% conversion. 
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